Form 4 ENANTA PHARMACEUTICALS For: Nov 20 Filed by: Or Yat Sun
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Enanta Pharma (ENTA) Posts Q4 Loss of 27c/Share
November 24, 2014 8:10 AM ESTEnanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($0.27), $0.06 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $3.81 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
... More